{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:33:34Z","timestamp":1791401614302,"version":"4.3.3"},"reference-count":58,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcyt.2024.03.491","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T08:52:11Z","timestamp":1712220731000},"page":"1076-1083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adipose-derived stromal vascular fraction cells to treat long-term pulmonary sequelae of coronavirus disease 2019: 12-month follow-up"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9611-252X","authenticated-orcid":false,"given":"Michael","family":"Carstens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessy","family":"Trujillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanury","family":"Dolmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Calderwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Lejarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3822-6019","authenticated-orcid":false,"given":"Kenneth","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2024.03.491_bib0001","unstructured":"World Health Organization. WHO coronavirus (COVID-19) dashboard, <https:\/\/covid19.who.int> [accessed 31.01.2024]."},{"key":"10.1016\/j.jcyt.2024.03.491_bib0002","unstructured":"World Health Organization. Post COVID-19 condition (long COVID), <https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/post-covid-19-condition.> [accessed 25.09.2023]."},{"key":"10.1016\/j.jcyt.2024.03.491_bib0003","unstructured":"Harvard Scholar. The economic cost of long COVID: an update, <https:\/\/scholar.harvard.edu\/files\/cutler\/files\/long_covid_update_7-22.pdf> [accessed 25.09.2023]."},{"issue":"10","key":"10.1016\/j.jcyt.2024.03.491_bib0004","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Infectious Dis (Lond)"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis and angiogenesis in Covid-19","volume":"383","author":"Ackerman","year":"2020","journal-title":"N Eng J Med"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0006","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/ajcp\/aqaa062","article-title":"COVID autopsies, Oklahoma, USA","volume":"153","author":"Barton","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0007","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/his.14134","article-title":"Post-mortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings of lungs and other organs suggesting vascular dysfunction","volume":"77","author":"Menter","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0008","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: A prospective cohort study","volume":"173","author":"Wichmann","year":"2020","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01217-2020","article-title":"Abnormal pulmonary function in Covid-019 patients at time of hospital discharge","volume":"55","author":"Mo","year":"2020","journal-title":"Eur Resp J"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cophys.2021.03.005","article-title":"Pulmonary function and Covid-19","volume":"21","author":"Thomas","year":"2021","journal-title":"Curr Opin Physiol"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0011","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3390\/diagnostics13061201","article-title":"Quantitative assessment of lung volume and enhancements in patients with Covid: role of dual-energy CT","volume":"13","author":"Foti","year":"2023","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.jcyt.2024.03.491_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36142","article-title":"Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge","volume":"4","author":"Bellan","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0013","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1038227","article-title":"Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: a prospective cohort study","volume":"13","author":"Bellan","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jcyt.2024.03.491_bib0014","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.jcyt.2024.03.491_bib0015","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","article-title":"Mesenchymal stem cells","volume":"9","author":"Caplan","year":"1991","journal-title":"J Orthop Res"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0016","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2147\/IJN.S355366","article-title":"Target therapy for inflammatory diseases with mesenchymal stem cells and their derived exosomes: from basic to clinics","volume":"17","author":"Wang","year":"2022","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.932360","article-title":"Bone marrow-derived mesenchymal stromal cell therapy in severe COVID-19: preliminary results of a phase I\/II clinical trial","volume":"13","author":"Gregoire","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0018","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3390\/jcm9030682","article-title":"MSC based therapies\u2014new perspectives for the injured lung","volume":"9","author":"Behnke","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0019","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12967-020-02380-2","article-title":"Rationale for clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients","volume":"18","author":"Rogers","year":"2020","journal-title":"J Translational Med"},{"issue":"1","key":"10.1016\/j.jcyt.2024.03.491_bib0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13287-022-02953-6","article-title":"Human placenta-derived mesenchymal stem cells transplanted in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase 1 clinical trial): safety profile assessment","volume":"13","author":"Aghayan","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13287-021-02165-4","article-title":"Mesenchymal stem cells derived from perinatal tissues for treatment of critically-ill ARDS patients: a case series","volume":"12","author":"Hashemin","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0022","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-15-39","article-title":"Treatment of acute respiratory distress syndrome with allogenic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study","volume":"15","author":"Zheng","year":"2014","journal-title":"Respiratory Res"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13287-022-02810-6","article-title":"Mesenchymal stem\/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, currently clinical evidence, and future perspectives","volume":"13","author":"Yao","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0024","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13287-022-02796-1","article-title":"Safety and long-term improvement of mesenchymal stromal cell infusion in critical COVID-19 patients: a randomized clinical trial","volume":"13","author":"Rebelatto","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41392-021-00754-6","article-title":"Mesenchymal stem cell therapy for severe COVID-19","volume":"6","author":"Shi","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103789","article-title":"Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial","volume":"75","author":"Shi","year":"2022","journal-title":"EBioMed"},{"issue":"12","key":"10.1016\/j.jcyt.2024.03.491_bib0027","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol Biol Cell"},{"issue":"1","key":"10.1016\/j.jcyt.2024.03.491_bib0028","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","article-title":"The MSC: an injury drugstore","volume":"9","author":"Caplan","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0029","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.yexcr.2005.04.029","article-title":"Functional studies of mesenchymal stem cells derived from adult adipose tissue","volume":"309","author":"Dicker","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jcyt.2013.02.006","article-title":"Stromal cells from the adipose tissue-derived stromal\/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)","volume":"15","author":"Bourin","year":"2013","journal-title":"Cytotherapy"},{"issue":"2","key":"10.1016\/j.jcyt.2024.03.491_bib0031","doi-asserted-by":"crossref","first-page":"216","DOI":"10.14336\/AD.2020.0228","article-title":"Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0032","doi-asserted-by":"crossref","first-page":"462","DOI":"10.14336\/AD.2020.0301","article-title":"Mesenchymal stem cell infusion shows promise for combating coronavirus (COVID-19)- induced pneumonia","volume":"11","author":"Shetty","year":"2020","journal-title":"Aging Dis"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100454","article-title":"Adipose derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-pneumonia requiring mechanical ventilation. A proof-of concept study","volume":"25","author":"Sanchez-Guijo","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1321303","article-title":"Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID- 19: a randomized controlled trial","volume":"10","author":"de Dios","year":"2023","journal-title":"Front Med."},{"key":"10.1016\/j.jcyt.2024.03.491_bib0035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ijms20215471","article-title":"Impact of different preparation methods to obtain human adipose-derived stromal vascular fraction cells (AD-SVFs) and human adipose-derived mesenchymal stem cells (AD-MSCs): enzymatic digestion versus mechanical centrifugation","volume":"20","author":"Gentile","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jcyt.2024.03.491_bib0036","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.14336\/AD.2020.0711","article-title":"Research progress on mesenchymal stem cells (MSCs), adipose-derived mesenchymal stem cells (AD-MSCs), drugs, and vaccines in inhibiting COVID-19 disease","volume":"1","author":"Gentile","year":"2020","journal-title":"Aging Dis"},{"issue":"7","key":"10.1016\/j.jcyt.2024.03.491_bib0037","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/14712598.2020.1761322","article-title":"Adipose-derived stromal cells (ASCs) as a new regenerative immediate therapy for combating coronavirus (COVID-19)-induced pneumonia","volume":"20","author":"Gentile","year":"2020","journal-title":"Exp Opinion Biologic Ther"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0038","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cps.2014.12.010","article-title":"Adipose tissue and stem and progenitor cells: discovery and development","volume":"42","author":"Kapur","year":"2015","journal-title":"Clin Plast Surg"},{"issue":"3","key":"10.1016\/j.jcyt.2024.03.491_bib0039","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/ten.tec.2016.0377","article-title":"Isolation of adipose-derived stromal vascular fraction cells using a novel point-of-care device: cell characterization and review of the literature","volume":"23","author":"Brown","year":"2017","journal-title":"Tiss Eng Part C Methods"},{"issue":"2","key":"10.1016\/j.jcyt.2024.03.491_bib0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.bjps.2015.10.015","article-title":"Stromal vascular fraction: a regenerative reality? Part 1: concepts and review of the literature","volume":"69","author":"Nguyen","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0041","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bjps.2015.10.014","article-title":"Stromal vascular fraction: a regenerative reality? Part 2: mechanisms of regenerative action","volume":"69","author":"Guo","year":"2016","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0042","first-page":"1435","article-title":"Anti-inflammatory effect of stromal vascular fraction cells in fat transplantation","volume":"17","author":"Zhu","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0043","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1002\/stem.2689","article-title":"Immunomodulatory effects of adipose stromal vascular fraction cells promote alternative interaction macrophages to repair tissue damage","volume":"35","author":"Bowles","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.102071","article-title":"Adipose-derived stromal vascular fraction (SVF) cells for the treatment of non-reconstructable peripheral vascular disease in patients with critical limb ischemia: a 6-year follow up showing durable effects","volume":"49","author":"Carstens","year":"2020","journal-title":"Stem Cell Res"},{"issue":"8","key":"10.1016\/j.jcyt.2024.03.491_bib0045","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/sctm.20-0497","article-title":"Treatment of chronic diabetic foot ulcers with adipose-derived stromal vascular fraction injections: safety and evidence of efficacy at 1 year","volume":"10","author":"Carstens","year":"2021","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"10.1016\/j.jcyt.2024.03.491_bib0046","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0363546519899923","article-title":"Clinical efficacy of intra-articular mesenchymal stromal cells for the treatment of knee osteoarthritis: A double-blinded, prospective, randomized, controlled clinical trial","volume":"489","author":"Garza","year":"2020","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0047","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), <https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50> [accessed 25.09.2023]."},{"issue":"12","key":"10.1016\/j.jcyt.2024.03.491_bib0048","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1164\/rccm.201105-0840OC","article-title":"Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important differences","volume":"184","author":"DuBois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcyt.2024.03.491_bib0049","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1081\/COPD-200053377","article-title":"Minimal clinically important differences in COPD lung function","volume":"2","author":"Donohue","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0050","series-title":"Practical pulmonary pathology: a diagnostic approach","first-page":"15","article-title":"Pulmonary function testing for pathologists","author":"Noth","year":"2018"},{"issue":"3","key":"10.1016\/j.jcyt.2024.03.491_bib0051","doi-asserted-by":"crossref","DOI":"10.1590\/1806-3713\/e20180065","article-title":"Reference values for pulmonary volumes by plethysmography in a Brazilian sample of white adults","volume":"45","author":"Lessa","year":"2019","journal-title":"J Bras Pneumol"},{"issue":"1","key":"10.1016\/j.jcyt.2024.03.491_bib0052","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/15412555.2014.898051","article-title":"Minimum clinically important difference in diffusing capacity of the lungs for carbon monoxide in patients with severe and very severe chronic obstructive pulmonary disease","volume":"12","author":"Horita","year":"2015","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.jcyt.2024.03.491_bib0053","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221806","article-title":"Long-term lung abnormalities associated with COVID-19 pneumonia","volume":"306","author":"Kanne","year":"2023","journal-title":"Radiology"},{"issue":"March","key":"10.1016\/j.jcyt.2024.03.491_bib0054","article-title":"Temporal changes in CT findings in 90 patients with COVID pneumonia: a longitudinal study","author":"Wang","year":"2020","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.jcyt.2024.03.491_bib0055","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2214\/AJR.14.13021","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) infection: chest CT findings","volume":"203","author":"Ajlan","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0056","unstructured":"Martinez-Sanchez 35 National Congress Spanish Society of Radiology Proceedings 2021; 1(1) <https:\/\/piper.espacio-seram.com\/index.php\/seram\/issue\/view\/4> [accessed 1.06.2023]."},{"key":"10.1016\/j.jcyt.2024.03.491_bib0057","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1148\/radiol.2020200343","article-title":"Chest Ct for typical coronavirus disease 2019 (COVID-19) pneumonia. Relationship to negative RT-PCR testing","volume":"296","author":"Xie","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jcyt.2024.03.491_bib0058","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13287-023-03522-1","article-title":"Adipose-derived autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program","volume":"14","author":"Vij","year":"2023","journal-title":"Stem Cell Res Ther"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924005681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924005681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T01:30:43Z","timestamp":1724376643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924005681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1465324924005681"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.03.491","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adipose-derived stromal vascular fraction cells to treat long-term pulmonary sequelae of coronavirus disease 2019: 12-month follow-up","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.03.491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}